These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


270 related items for PubMed ID: 30247266

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness.
    Cain DM, Vang D, Simone DA, Hebbel RP, Gupta K.
    Br J Haematol; 2012 Feb; 156(4):535-44. PubMed ID: 22171826
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of sex disparities in opioid use among ED patients with sickle cell disease, 2006-2015.
    Wilson TT, Chou SC, Becker S, Schuur JD, Beaudoin F.
    Am J Emerg Med; 2021 Dec; 50():597-601. PubMed ID: 34592567
    [Abstract] [Full Text] [Related]

  • 28. Δ9-Tetrahydrocannabinol Alleviates Hyperalgesia in a Humanized Mouse Model of Sickle Cell Disease.
    Mabou Tagne A, Fotio Y, Gupta K, Piomelli D.
    J Pharmacol Exp Ther; 2024 Oct 18; 391(2):174-181. PubMed ID: 38955494
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Exploring the role of viscosity-vaso-occlusion and haemolysis-endothelial dysfunction in pain sensitization among Jamaicans with sickle cell disease.
    Ramsay Z, Ali A, Grant J, Asnani M.
    Br J Haematol; 2024 Oct 18; 205(4):1570-1580. PubMed ID: 39081251
    [Abstract] [Full Text] [Related]

  • 31. Cold-evoked pain varies with skin type and cooling rate: a psychophysical study in humans.
    Harrison JL, Davis KD.
    Pain; 1999 Nov 18; 83(2):123-35. PubMed ID: 10534583
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. An Evaluation of Central Sensitization in Patients With Sickle Cell Disease.
    Campbell CM, Moscou-Jackson G, Carroll CP, Kiley K, Haywood C, Lanzkron S, Hand M, Edwards RR, Haythornthwaite JA.
    J Pain; 2016 May 18; 17(5):617-27. PubMed ID: 26892240
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Body Mass Index and the Association With Vaso-occlusive Crises in Pediatric Sickle Cell Disease.
    Zivot A, Apollonsky N, Gracely E, Raybagkar D.
    J Pediatr Hematol Oncol; 2017 May 18; 39(4):314-317. PubMed ID: 28221266
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Vaso-occlusive painful events in sickle cell disease: impact on child well-being.
    Brandow AM, Brousseau DC, Pajewski NM, Panepinto JA.
    Pediatr Blood Cancer; 2010 Jan 18; 54(1):92-7. PubMed ID: 19653296
    [Abstract] [Full Text] [Related]

  • 39. Sensitization of nociceptors by prostaglandin E2-glycerol contributes to hyperalgesia in mice with sickle cell disease.
    Khasabova IA, Uhelski M, Khasabov SG, Gupta K, Seybold VS, Simone DA.
    Blood; 2019 May 02; 133(18):1989-1998. PubMed ID: 30796025
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.